Who reports and when, for the weeks ahead. The schedule comes from an outside feed; every figure beside it — the grade, the size, the multiple — is computed from the company's own SEC filings.
2,363 companies scheduled this month, 2330 of them covered here.
| Company | Grade | Size | P/E | Figures |
|---|---|---|---|---|
A | $82.8B | 29.34 | — | |
B | $59.7B | 22.64 | — | |
B | $55.5B | 18.77 | — | |
D | $44.6B | 163.97 | — | |
C | $32.4B | 7.44 | — | |
| Company | Grade | Size | P/E | Figures |
|---|---|---|---|---|
C | $345.9B | 16.65 | — | |
A | $207B | 65.65 | — | |
A | $169B | 29.74 | — | |
A | $158.3B | 19.31 | — | |
A | $136.7B | 72.48 | — | |
| $23.6B |
| 15.10 |
| — |
C | $6.8B | 75.94 | — |
C | $5.7B | 46.48 | — |
D | $3.2B | 34.11 | — |
B | $2B | — | — |
B | $1.2B | 5.55 | — |
D | $874.1M | — | — |
B | $698M | 98.38 | — |
| $121.9B |
| 1.23 |
| — |
A | $82.8B | — | — |
A | $80.2B | 30.45 | — |
A | $78B | 22.99 | — |
C | $76.2B | 29.37 | — |
D | $69.7B | 16.09 | — |
A | $63B | 55.40 | — |
A | $54.8B | 14.98 | — |
C | $46B | 36.20 | — |
A | $44.9B | 33.40 | — |
B | $37.6B | 21.45 | — |
B | $28.8B | 13.07 | — |
A | $25.7B | 55.42 | — |
| LH | B | $25B | 25.54 | — |
| INCY | A | $24.6B | 17.41 | — |
| HUBB | A | $24.3B | 27.12 | — |
| VLTO | A | $23.7B | 24.91 | — |
| XYL | A | $23.6B | 24.03 | — |
| VMRK | C | $23B | 26.55 | — |
| THC | A | $20.8B | 9.94 | — |
| AMRZ | C | $20.6B | 17.22 | — |
| EIX | B | $20.6B | 5.81 | — |
| EXE | A | $19.5B | 7.27 | — |
| WPC | C | $15B | — | — |
| SIM | D | $14.6B | — | — |
| LOGI | A | $14.4B | 18.48 | — |
| NBIX | A | $14.1B | 20.29 | — |
| ARCC | Not rated | $13.9B | 14.34 | — |
| INIO | Not rated | $13.8B | — | — |
| RNR | B | $13.5B | 5.43 | — |
| IVZ | A | $13.4B | — | — |
| CHKP | A | $13.4B | 13.00 | — |
| W | A | $13.4B | — | — |
| REG | A | $13.3B | — | — |
| SWKS | F | $13.2B | 45.60 | — |
| AIT | B | $12.3B | 30.70 | — |
| RGEN | A | $11B | 266.60 | — |
| CSGP | B | $10.9B | 141.84 | — |
| TX | F | $10.7B | 24.29 | — |
| AUR | D | $10.6B | — | — |
| QRVO | C | $10.3B | 32.24 | — |
| UMBF | A | $10B | 10.96 | — |
| BXP | A | $9.9B | 33.20 | — |
| MOD | B | $9.8B | 69.08 | — |
| FLS | C | $9.4B | 25.73 | — |
| ESI | C | $8.8B | 58.01 | — |
| RRC | B | $8.6B | 10.19 | — |
| AOS | B | $8B | 16.12 | — |
| ZWS | B | $7.8B | 37.76 | — |
| SFD | C | $7.5B | 7.09 | — |
| AXTA | B | $7B | 19.09 | — |
| MSA | A | $7B | 22.47 | — |
| AWI | A | $6.9B | 22.31 | — |
| ALKS | B | $6.8B | 107.37 | — |
| CHE | B | $6.7B | 25.76 | — |
| KNSA | A | $6.2B | 83.26 | — |
| ST | B | $6.1B | 69.80 | — |
| CVLT | A | $6.1B | 93.13 | — |
| CZR | B | $6B | — | — |
| VFC | B | $5.7B | 23.02 | — |
| VRNS | B | $5.4B | — | — |
| MMYT | A | $5.4B | 56.75 | — |
| CAKE | A | $5.3B | 29.09 | — |
| EXLS | B | $5.3B | 22.16 | — |
| AROC | A | $5.3B | 16.12 | — |
| CGAU | Not rated | $4.4B | — | — |
| FELE | B | $4.3B | 29.10 | — |
| HRI | A | $4.3B | 83.10 | — |
| ENPH | D | $4.2B | 31.86 | — |
| CECO | Not rated | $4.1B | — | — |
| MIR | A | $3.9B | 143.35 | — |
| SEB | F | $3.9B | — | — |
| UCTT | D | $3.6B | — | — |
| RNST | A | $3.6B | 11.64 | — |
| DBVT | F | $3.4B | — | — |
| HNI | C | $3.4B | — | — |
| ARQT | A | $3.4B | 127.33 | — |
| RCUS | D | $3.3B | — | — |
| KAI | A | $3.2B | 28.71 | — |
| LRN | A | $3.1B | 10.51 | — |
| ABG | B | $3.1B | 6.49 | — |
| PII | D | $3B | — | — |
| CURB | B | $2.9B | 90.05 | — |
| RRR | C | $2.9B | 17.26 | — |
| GPI | D | $2.9B | 9.97 | — |
| AKR | B | $2.6B | 84.85 | — |
| TRMK | A | $2.6B | 11.51 | — |
| HURN | B | $2.5B | 26.71 | — |
| BUSE | A | $2.4B | 12.09 | — |
| FCPT | A | $2.4B | 19.86 | — |
| APAM | B | $2.4B | 8.84 | — |
| NEO | B | $2.4B | — | — |
| IVT | A | $2.4B | 152.10 | — |
| NTB | B | $2.3B | 10.70 | — |
| MBIN | A | $2.3B | 9.97 | — |
| WGS | C | $2.3B | — | — |
| BLX | A | $2.1B | 9.09 | — |
| FCF | A | $2.1B | 12.47 | — |
| HYMC | Not rated | $1.8B | — | — |
| HOPE | C | $1.7B | 13.44 | — |
| CTS | C | $1.7B | 25.29 | — |
| JBLU | D | $1.6B | — | — |
| GIC | B | $1.6B | 19.00 | — |
| TRS | F | $1.4B | 1.64 | — |
| AAT | B | $1.3B | 73.55 | — |
| GBX | F | $1.3B | 12.17 | — |
| RYZ | D | $1.2B | — | — |
| AMTB | C | $1.1B | 20.95 | — |
| CPAC | A | $1B | 17.94 | — |
| CAC | A | $948.1M | 10.75 | — |
| FCBC | A | $892.9M | 14.89 | — |
| THFF | A | $883.3M | 10.40 | — |
| TTI | D | $861M | 193.83 | — |
| IBCP | A | $784.7M | 10.28 | — |
| BCAL | B | $688.7M | 11.58 | — |
| JBGS | F | $598.3M | — | — |
| KIDS | B | $595M | — | — |
| SSII | C | $574.1M | — | — |
| SFST | B | $563.2M | 12.81 | — |
| BRSP | C | $511.2M | — | — |
| NXRT | F | $492.5M | — | — |
| TRTX | B | $490.1M | 9.91 | — |
| ILPT | A | $479.2M | — | — |
| LXFR | D | $462.4M | 59.59 | — |
| QUAD | F | $460.8M | 16.59 | — |
| CHCT | B | $412.9M | 21.51 | — |
| ORN | B | $340.4M | 40.05 | — |
| RCKY | B | $339.8M | 11.87 | — |
| CLW | D | $312.4M | — | — |
| HRZN | Not rated | $311M | 11.90 | — |
| CBNA | A | $310.8M | 11.67 | — |
| FRAF | A | $280.7M | 11.36 | — |
| WNEB | C | $277.2M | 16.46 | — |
| GBFH | C | $271.3M | 14.60 | — |
| PAMT | F | $249.8M | — | — |
| QNBC | D | $227.4M | 13.55 | — |
| CWH | F | $219.5M | — | — |
| RBKB | C | $200M | 14.05 | — |
| PERF | B | $193M | 37.90 | — |
| FNWD | C | $182.3M | 18.54 | — |
| EBMT | B | $169.4M | 10.37 | — |
| ATOM | D | $164.7M | — | — |
| RVSB | F | $118.7M | — | — |
| SFBC | C | $117.5M | 14.67 | — |
| PROV | C | $114.5M | 17.83 | — |
| TYGO | D | $64.7M | 4.96 | — |
| TZOO | B | $56.5M | 198.59 | — |
| FSP | D | $37.3M | — | — |
| JL | A | $17.7M | 5.89 | — |
| MGIH | F | $16.3M | — | — |
| AQB | Not rated | $4.9M | — | — |
| ZDGE | A | $1.6M | — | — |
| AKO.Anot covered | Not rated | — | — | — |
| AKO.Bnot covered | Not rated | — | — | — |
| FMX | B | — | — | — |
| NBNnot covered | Not rated | — | — | — |
| V | B | — | — | — |